Skip to main content
Home
  • Catalog
  • Online payment
  • Join us
  • My Cerba
EN
  • About us

    Cerba is a leading reference in specialized medical biology in France and internationally. For over 50 years, it has been leveraging its medical expertise and strong capacity for innovation to serve patients, healthcare professionals, and the pharmaceutical industry.

    • Cerba, leader in specialized clinical pathology
    • Our governance
    • Our missions
    • Our innovations
    • Clinical research projects
    • Our CSR policy
    • Our quality commitments
    • Our values
    • Cerba HealthCare group
  • Our expertise

    Since 1967, Cerba has been leveraging its expertise and innovation to serve healthcare. Recognized in France and internationally, our laboratory is a leading player in specialised medical biology, offering a high level of excellence for patients and healthcare professionals.

    • Allergology
    • Autoimmunity
    • Specialized biochemistry
    • Genetics and cytogenetics
    • Hematology
    • Infectiology
    • Oncology
    • Onco-hematology
    • Pharmacology
    • Toxicology
    • Clinical trial biology
  • Training and resources

    We are committed daily to placing medical biology at the heart of the care pathway to improve patient management in terms of prevention, diagnosis, and monitoring of diseases. This involves medical and technical expertise, innovation, as well as a range of training programs and a constantly evolving array of services and tools.

    • Certified Scientific Training Programs
    • Cerba Live Sessions
    • Podcast - Biomedically Yours
    • My Cerba portal
    • Customer care - practical tutorials
    • Cerba Flash - the connected prescription
    • The journey of a sample
    • FAQ
  • Our news
  • Contact us
  • Catalog
  • Online payment
  • Join us
  • My Cerba
  • Catalogue...
  • UNEXPECTED ANTIBODY DETECTION (EXCEPETD ANTI-A OR ANTI-B) / TRANSMITTED

unexpected antibody detection (excepetd anti-a or anti-b) / transmitted

Updated on

The exam, in brief

hn

Select a nature

LCSD Code

11141

Discover our medical news

  • AdobeStock_10187711032.jpeg
    Cerba Live Session
    11 September 2025
    [Cerba Live Session] Alcohol and Biomarkers: Which Tests for Which Situations?
  • CLS74.jpg
    Cerba Live Session
    5 June 2025
    [REPLAY] The Kappa Index: a new biomarker in the diagnosis of Multiple Sclerosis (MS)
  • Capture d'écran 2025-06-11 165034.png
    In the media
    4 June 2025
    CEO Cerba HealthCare Nomination
  • Camille d'Humière BD 045 2.png
    In the media
    26 May 2025
    Article Le Monde Sciences "Le microbiote vaginal, l’écosystème trop peu connu qui régule la santé des femmes"
Browse the news
Need help?

Need help?

Diagnosis, classification, choice and monitoring of treatment, ...
From the selection of exams to the interpretation of results and therapeutic recommendations, our experts are there to help you. Ask for their advice.

Contact an expert
About us
  • Cerba, leader in specialized clinical pathology
  • Our governance
  • Our missions
  • Our innovations
  • Clinical research projects
  • Our CSR policy
  • Our quality commitments
  • Our values
  • Cerba HealthCare group
Our expertise
  • Allergology
  • Autoimmunity
  • Specialised biochemistry
  • Genetics and cytogenetics
  • Hematology
  • Infectiology
  • Oncology
  • Onco-hematology
  • Pharmacology
  • Toxicology
  • Clinical trial biology
Training and resources
  • Certified Scientific Training Programs
  • Cerba Live Session
  • Podcast - Biomedically Yours
  • My Cerba portal
  • Customer care - practical tutorials
  • Cerba Flash - the connected prescription
  • The journey of a sample
  • FAQ
  • Historique des documents
  • Mentions Légales
  • Politique de protection des données
© Lab Cerba